Legend
| A | Day + Poster Area |
| B | Session |
| C | Poster Number |
Example: D2P3.10.07 = Day 2, Poster Area 3, Session 10 and Poster Nr 07
×
Search :| # | ID | Presenter | A | B | C | Session | Title |
|---|---|---|---|---|---|---|---|
| 1 | 43595_78 | Meyad Alkarni | D1P1 | 01 | 01 | BASIC SCIENCE 1 | Early Insights into Immunological and Transcriptomic Signatures Related to Radiological Severity in Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) |
| 2 | 44087_445 | Braune Anna Z. | D1P1 | 01 | 02 | BASIC SCIENCE 1 | Feasibility and Safety of Outpatient Parenteral Antibiotic Therapy (OPAT) in Adults with Cystic Fibrosis, Bronchiectasis, Primary Ciliary Dyskinesia and NTM Pulmonary Disease – a Single-Center, Retrospective Cohort Study |
| 3 | 43986_344 | Crystal Bourke | D1P1 | 01 | 03 | BASIC SCIENCE 1 | Mucus is hyperconcentrated in children with bronchiectasis compared to healthy children |
| 4 | 43831_204 | Erin Cant | D1P1 | 01 | 04 | BASIC SCIENCE 1 | Mucociliary clearance in the lower airways in bronchiectasis: data from the BRILLIANT study |
| 5 | 43871_242 | Raphael Ewen | D1P1 | 01 | 05 | BASIC SCIENCE 1 | Evaluation of Serum Azurocidin (AZU-1) as a potential biomarker of disease activity and predictor of exacerbations in adults with bronchiectasis: Data from the German Bronchiectasis Registry PROGNOSIS |
| 6 | 44069_428 | Paola Faverio | D1P1 | 01 | 06 | BASIC SCIENCE 1 | Impact of geographic and climatic variables and environmental athmospheric pollutants on pulmonary NTM infections: an Italian nationwide case-control study |
| 7 | 43708_96 | Laura Fawcett | D1P1 | 01 | 07 | BASIC SCIENCE 1 | STAKEHOLDER ACCEPTABILITY OF PATIENT-DERIVED ORGANOIDS FOR PERSONALISED MEDICINE IN CYSTIC FIBROSIS |
| 8 | 43875_245 | Hye Young Hong | D1P1 | 01 | 08 | BASIC SCIENCE 1 | Body mass index trajectory and the risk of bronchiectasis exacerbation: An analysis of the KMBARC cohort |
| 9 | 44191_491 | ATIQUR RAHMAN KHAN | D1P1 | 01 | 09 | BASIC SCIENCE 1 | Modern Approaches to Paediatric Bronchiectasis: From Early Recognition to Precision Therapy |
| 10 | 43398_51 | Linda Kunz | D1P1 | 01 | 10 | BASIC SCIENCE and REGISTRIES SESSION | Bronchoalveolar lavage as a diagnostic tool for assessing disease activity in bronchiectasis |
| 11 | 43746_121 | Melissa McDaniel | D1P1 | 01 | 11 | BASIC SCIENCE and REGISTRIES SESSION | A secreted factor of Pseudomonas aeruginosa rapidly kills non-tuberculous mycobacteria in biofilms in vitro |
| 12 | 44197_496 | Sonja Momchilovikj | D1P1 | 01 | 12 | BASIC SCIENCE and REGISTRIES SESSION | Clinical and Microbiological Characteristics of Hospitalized Patients with Bronchiectasis – A One-Year Retrospective Analysis in North Macedonia |
| 13 | 43399_52 | Ilgar Mustafayev | D1P1 | 01 | 13 | BASIC SCIENCE and REGISTRIES SESSION | Relationship between the Severity of the Clinical Course of primary bronchiectasis (BE) and Family and Genetic History |
| 14 | 43833_206 | Nariné Baririan | D1P1 | 02 | 01 | BASIC SCIENCE and REGISTRIES SESSION | Florensocatib (dipeptidyl peptidase-1 inhibitor) Phase I study in healthy Caucasian subjects |
| 15 | 43731_113 | Joe Brew | D1P1 | 02 | 02 | BASIC SCIENCE and REGISTRIES SESSION | Validation of a Privacy-Preserving Cough Monitoring Smartwatch Against Human-Annotated Ground Truth in Adults with Chronic Cough: A Decentralized, Real-World Study |
| 16 | 43789_169 | Zhongbo Chen | D1P1 | 02 | 03 | BASIC SCIENCE and REGISTRIES SESSION | Comparison of High-Flow Humidified Nasal Oxygen Therapy and Non-invasive Ventilation as an Initial Ventilation Strategy in Acute Exacerbation of Bronchiectasis with Mild to Moderate Hypercapnia:Study Protocol |
| 17 | 43860_232 | Zhongbo Chen | D1P1 | 02 | 04 | BASIC SCIENCE and REGISTRIES SESSION | Efficacy and Safety of High-Flow Nasal Cannula Oxygen Therapy versus Conventional Oxygen Therapy in Patients with Acute Exacerbation of Bronchiectasis: Study Protocol for a Multicenter, Randomized Controlled Trial |
| 18 | 43404_54 | James D. Chalmers | D1P1 | 02 | 05 | REGISTRIES & TRAILS 1 | Florensocatib, an inhibitor of dipeptidyl peptidase-1, for the treatment of non-cystic fibrosis bronchiectasis: Rationale and Design of the FABLE Phase III trial |
| 19 | 43779_160 | James D. Chalmers | D1P1 | 02 | 06 | REGISTRIES & TRAILS 1 | Subgroup analysis: AIRLEAF® Phase II study of a dipeptidyl peptidase 1 (DPP1, or CatC) inhibitor, verducatib, in adults with non–cystic fibrosis bronchiectasis |
| 20 | 43888_255 | Raya Cohen | D1P1 | 02 | 07 | REGISTRIES & TRAILS 1 | Long term outcomes of patients with Nocardia isolation in respiratory secretions – a retrospective cohort study |
| 21 | 43899_265 | Meg Crisafulli | D1P1 | 02 | 08 | REGISTRIES & TRAILS 1 | The Australian Bronchiectasis Registry: Demographic and Aetiological Characteristics of a National Adult and Paediatric Cohort |
| 22 | 43933_292 | Fabiana Cusati | D1P1 | 02 | 09 | REGISTRIES & TRAILS 1 | Effectiveness of inhaled colistin in bronchiectasis: a real-world analysis from the REPAIR registry. |
| 23 | 43828_201 | Patrick A. Flume | D1P1 | 02 | 10 | REGISTRIES & TRAILS 1 | Clinical outcome burden in people with bronchiectasis by baseline pulmonary exacerbation frequency: A real-world data analysis |
| 24 | 44057_417 | Lingyun Gao | D1P1 | 02 | 11 | REGISTRIES & TRAILS 1 | Development and Validation of an Inflammation-Nutrition-CT Integrated Risk Score (INCT-RS) for Predicting Progression from Asymptomatic Radiological Bronchiectasis to Clinical Bronchiectasis |
| 25 | 44067_426 | Rebecca Hull | D1P1 | 02 | 12 | REGISTRIES & TRAILS 1 | Inhaled Aztreonam lysine to treat chronic Gram-negative infections in patients with bronchiectasis: results from the VITAL-BE trial |
| 26 | 44071_430 | Merete B Long | D1P1 | 02 | 13 | REGISTRIES & TRAILS 1 | Alpha-1 antitrypsin augmentation in people with bronchiectasis and neutrophilic airway inflammation: results from the proof-of-concept BATMAN trial |
| 27 | 43921_281 | Pontus Mertsch | D1P1 | 02 | 14 | REGISTRIES & TRAILS 1 | InhalEd ColiFin® in adult bRonchiectasis pAtients with new asymptomatic PseuDomonas aerugInosa infeCtion– an open-lAbel, proof of concepT- randomizEd controlled trial (ERADICATE) |
| 28 | 44193_493 | Sayina Abudukeyoumu | D1P1 | 03 | 01 | Comorbidities, Immunology & Inflammation 1 | Development and validation of a prognostic score for ABPA relapse: a retrospective-prospective cohort study |
| 29 | 43826_199 | Ke Li Chow | D1P1 | 03 | 02 | Comorbidities, Immunology & Inflammation 1 | Identification of novel autoantibodies to unlock targeted treatments and diagnostics in idiopathic non-cystic fibrosis bronchiectasis |
| 30 | 43840_216 | Carlos Gallego Mol | D1P1 | 03 | 03 | Comorbidities, Immunology & Inflammation 1 | The Progressive Burden of Bronchiectasis: Comparing Quality of Life Outcomes Between Hospitalised and Non-Hospitalised Patients in BronchUK |
| 31 | 44077_436 | Jiahui He | D1P1 | 03 | 04 | Comorbidities, Immunology & Inflammation 1 | Serum Azurocidin-1 in bronchiectasis: a pilot study exploring clinical associations |
| 32 | 43798_178 | Raksha Jain | D1P1 | 03 | 05 | Comorbidities, Immunology & Inflammation 1 | Sex-specific and estrogen modulation of neutrophil function in bronchiectasis with and without cystic fibrosis |
| 33 | 43753_128 | Chrysavgi Kosti | D1P1 | 03 | 06 | Comorbidities, Immunology & Inflammation 1 | Phenotyping eosinophilic inflammation spectrum in bronchiectasis: data from a single centre in Greece |
| 34 | 43901_267 | Chaabouni Malek | D1P1 | 03 | 07 | Comorbidities, Immunology & Inflammation 1 | Case Report: Broncholithiasis in a Patient with Bronchiectasis and COPD |
| 35 | 43825_198 | Keshav Mangalick | D1P1 | 03 | 08 | Comorbidities, Immunology & Inflammation 1 | Cachexia is associated with Distinct Microbiome Signatures in the Lower Airway of Patients with Bronchiectasis |
| 36 | 43643_86 | Doreen Addrizzo-Harris | D1P2 | 04 | 01 | Cystic Fibrosis and Bronchiectasis 1 | Efficacy and Safety of Brensocatib in Patients of Asian Race with Non-cystic Fibrosis Bronchiectasis (NCFB): A Subgroup Analysis of the ASPEN Trial |
| 37 | 44083_441 | Doha BENCHAJI | D1P2 | 04 | 02 | Cystic Fibrosis and Bronchiectasis 1 | Clinical and Radiological Profile of Cystic Fibrosis Associated Bronchiectasis: A Descriptive Study of 19 Patients in Morocco |
| 38 | 43897_263 | Judy M Bradley | D1P2 | 04 | 03 | Cystic Fibrosis and Bronchiectasis 1 | Unsupervised home spirometry versus supervised clinic spirometry: Analysis of longitudinal participant-level data from the CLEAR trial in patients with bronchiectasis |
| 39 | 43771_145 | Amanda Brunton | D1P2 | 04 | 04 | Cystic Fibrosis and Bronchiectasis 1 | Association of Inhaled Corticosteroid Use and Clinical Outcomes in Patients with Bronchiectasis |
| 40 | 43190_33 | Isaac Cohen | D1P2 | 04 | 05 | Cystic Fibrosis and Bronchiectasis 1 | MCCSA2 a Combination of the b- agonist Formoterol and the Cholinergic Agonist Methacholine Induce Synergistic Activation of Mucociliary Clearance in a CFTR Independent Manner |
| 41 | 43808_185 | Annemarie T. Engel | D1P2 | 04 | 06 | Cystic Fibrosis and Bronchiectasis 1 | Pediatric simulations of verducatib (BI 1291583) in adolescents to support Phase III dose selection |
| 42 | 44076_435 | Ashleigh Foubister | D1P2 | 04 | 07 | Cystic Fibrosis and Bronchiectasis 1 | Impaired B-cell responses to P. aeruginosa and their impact on antibody production in bronchiectasis; a substudy in the EMBARC-BRIDGE cohort |
| 43 | 44061_421 | Rui Jiang | D1P2 | 04 | 08 | Cystic Fibrosis and Bronchiectasis 1 | Plasma Proteomic Signatures for Incident Bronchiectasis: Causal Validation, Severity Stratification, and Predictive Modeling |
| 44 | 43772_146 | Joseph Kibbler | D1P2 | 04 | 09 | Cystic Fibrosis and Bronchiectasis 1 | BRACE - a multicentre UK audit of multidisciplinary bronchiectasis care |
| 45 | 43754_129 | Jinliang Kong | D1P2 | 04 | 10 | Cystic Fibrosis and Bronchiectasis 1 | Navigating Therapeutic Dilemmas: Management of Pseudomonas aeruginosa Pneumonia in a Patient with Severe Immune Thrombocytopenia and Underlying Bronchiectasis—A Case Report |
| 46 | 44195_495 | Mariana Lima | D1P2 | 04 | 11 | Cystic Fibrosis and Bronchiectasis 1 | A rare X-linked cause of bronchiectasis |
| 47 | 43546_77 | Jia hui He | D1P2 | 04 | 12 | Cystic Fibrosis and Bronchiectasis 1 | Platelet count, clinical outcomes, and antibiotic and anti-inflammatory treatment in adults with bronchiectasis |
| 48 | 44058_418 | Rachel Anderson | D1P2 | 05 | 01 | Management & Organization of clinical service | Optimising paediatric to adult transition clinics for patients with Non-Cystic Fibrosis Bronchiectasis: A thematic analysis of data collected from service users and healthcare professionals |
| 49 | 43929_288 | Lucy Burr | D1P2 | 05 | 02 | Management & Organization of clinical service | Recognising Diffuse Panbronchiolitis in Multicultural Bronchiectasis Populations: The Diagnostic Value of Nasal Nitric Oxide |
| 50 | 43947_345 | Anthony De Soyza | D1P2 | 05 | 03 | Management & Organization of clinical service | UK Clinician Access, Utilisation and Eligibility Perspectives Genetic testing in Bronchiectasis: A National Survey |
| 51 | 43846_225 | Warnakulasuriya Susanne Nirodhani Fernando | D1P2 | 05 | 04 | Management & Organization of clinical service | Knowledge, Attitudes, and Practices Regarding Clinical Management of Bronchiectasis Among Doctors Managing Adult Respiratory Illnesses in Sri Lanka: A Cross-Sectional Study |
| 52 | 43699_93 | Nikolas Johl | D1P2 | 05 | 05 | Management & Organization of clinical service | Diagnostic Detectives: outcomes from the case files of a regional bronchiectasis diagnostic clinic |
| 53 | 43812_188 | Peter Kahn | D1P2 | 05 | 06 | Management & Organization of clinical service | Importance of Understanding the Patient Experience in Healthcare: An Example of the Integrated Patient Journey in Non-Cystic Fibrosis Bronchiectasis |
| 54 | 43814_189 | Peter A Kahn | D1P2 | 05 | 07 | Management & Organization of clinical service | Caregiver Perspectives on Pediatric Non-Cystic Fibrosis Bronchiectasis Clinical Trial Design: Insights from US Caregiver Panels |
| 55 | 43930_289 | Keating Rebecca | D1P2 | 05 | 08 | Management & Organization of clinical service | Improving access to airway clearance devices in bronchiectasis: A service evaluation of Aerobika provision through a Mater Foundation initiative |
| 56 | 43879_248 | Simone Tunesi | D1P2 | 05 | 09 | Management & Organization of clinical service | Unity is strength: early results from a joint pulmonology–infectious diseases outpatient clinic for the management of infectious complications of bronchiectasis at the Alessandria University Hospital |
| 57 | 44140_485 | Sophia MĂĽller | D1P2 | 06 | 01 | NTM 1 | Molecular identification and resistance profile of respiratory NTM strains in a single center over a five-year period |
| 58 | 44092_448 | Rosa Andrade | D1P2 | 06 | 02 | NTM 1 | Species Distribution and Geographic Clustering of Nontuberculous Mycobacterial Isolates at UC Irvine Medical Center, 2020–2024 |
| 59 | 43493_66 | Chih Jung Chang | D1P2 | 06 | 03 | NTM 1 | Drug Susceptibility Profiles of Clinically Relevant Nontuberculous Mycobacteria in Patients with Bronchiectasis: An Update from a Medical Center |
| 60 | 43749_124 | Hayoung Choi | D1P2 | 06 | 04 | NTM 1 | Risk of mycobacterial lung disease in lung cancer survivors: A nationwide longitudinal study |
| 61 | 44021_413 | Paola Faverio | D1P2 | 06 | 05 | NTM 1 | High Prevalence of Malnutrition and Sarcopenia in patients with NTM pulmonary disease in a High-Income Country |
| 62 | 44023_414 | Anas Hadeh | D1P2 | 06 | 06 | NTM 1 | Solitary Pulmonary Nodules in Nontuberculous Mycobacterial Infection: An Underrecognized Presentation in Bronchoscopy Practice |
| 63 | 43809_186 | Eric Houpt | D1P2 | 06 | 07 | NTM 1 | Clinical outcomes in a prospective cohort of 105 adults with speciated Mycobacterium avium complex lung disease, 2021-2026 |
| 64 | 43926_286 | Hyung-Jun Kim | D1P2 | 06 | 08 | NTM 1 | Pulmonary Rehabilitation in Nontuberculous Mycobacterial Pulmonary Disease: A Prospective Cohort Study |
| 65 | 43781_162 | NITYANAND JAIN | D1P2 | 06 | 09 | NTM 1 | Operational Constraints Shape Real-World Weighting of NTM-PD Diagnostic Domains in Clinical Decision-Making |
| 66 | 43889_256 | Meg Crisafulli | D1P2 | 07 | 01 | Allied Healthcare & Patients | Identifying international research priorities for bronchiectasis |
| 67 | 43834_207 | Anthony De Soyza | D1P2 | 07 | 02 | Allied Healthcare & Patients | Learning Points from Patient Experiences of Video-Supported Recruitment: A SWAT within the BOAT Trial |
| 68 | 43855_227 | Linda Esposito | D1P2 | 07 | 03 | Allied Healthcare & Patients | Early Real-World Experience with Brinsupri†on Airway Clearance and Clinical Symptoms in Bronchiectasis |
| 69 | 43925_285 | Rebecca Keating | D1P2 | 07 | 04 | Allied Healthcare & Patients | Redefining Bronchiectasis Care: What Patients Experience in a CF-Inspired Multidisciplinary Clinic |
| 70 | 43862_234 | Annemarie Lee | D1P2 | 07 | 05 | Allied Healthcare & Patients | Prevalence, clinical effects and treatment options for urinary incontinence in people with bronchiectasis: a systematic review |
| 71 | 43861_233 | Annemarie Lee | D1P2 | 07 | 06 | Allied Healthcare & Patients | Telehealth healthcare delivery in adults with bronchiectasis: a systematic review |
| 72 | 43863_235 | Annemarie Lee | D1P2 | 07 | 07 | Allied Healthcare & Patients | Telehealth physiotherapy for adults with bronchiectasis: a controlled trial |
| 73 | 43783_164 | Jordan Louie | D1P2 | 07 | 08 | Allied Healthcare & Patients | Pediatric to adult transition pathway in a PCD Clinic: impacts on patients and their families |
| 74 | 43821_196 | Judy Schloss | D1P2 | 07 | 09 | Allied Healthcare & Patients | Real-World Airway Clearance Practices in Bronchiectasis- A Patient Reported Survey |
| 75 | 43786_166 | Emily Ward | D1P2 | 07 | 10 | Allied Healthcare & Patients | Living Life with Bronchiectasis: A patient experience survey from the LiveBE study |
| 76 | 43827_200 | Shapaguli Aizezi | D1P3 | 08 | 01 | PCD and Paediatrics 1 | Diffuse Bronchiolitis as a Respiratory Phenotype in Chinese Children with Primary Ciliary Dyskinesia: A Clinical and Genetic Study |
| 77 | 43829_202 | Shapaguli Aizezi | D1P3 | 08 | 02 | PCD and Paediatrics 1 | Evaluation of Screening Tools and Early Diagnostic Predictors for Primary Ciliary Dyskinesia in Chinese Children |
| 78 | 44078_437 | Doha BENCHAJI | D1P3 | 08 | 03 | PCD and Paediatrics 1 | Clinical and Etiological Profile of Bronchiectasis in Morocco |
| 79 | 44074_433 | Doha Benchaji | D1P3 | 08 | 04 | PCD and Paediatrics 1 | From underdiagnosis to genetic confirmation: unveiling Primary Ciliary Dyskinesia in Morocco |
| 80 | 43987_346 | Crystal Bourke | D1P3 | 08 | 05 | PCD and Paediatrics 1 | Longitudinal lung clearance index measurements in children and adolescents with bronchiectasis |
| 81 | 44214_506 | Jessica Melfis Cemlyn-Jones | D1P3 | 08 | 06 | PCD and Paediatrics 1 | One Mutation, Three Lives: Variable Expression of Primary Ciliary Dyskinesia Type 7 in Siblings |
| 82 | 43870_241 | Raphael Ewen | D1P3 | 08 | 07 | PCD and Paediatrics 1 | Dupilumab for chronic rhinosinusitis with nasal polyps in adults with primary ciliary dyskinesia: a case series |
| 83 | 43912_275 | Moshe Heching | D1P3 | 08 | 08 | PCD and Paediatrics 1 | Recombinant Human DNase in Primary Ciliary Dyskinesia: A Multi-Center Randomized Controlled Trial Protocol |
| 84 | 43748_123 | Nena Karavasiloglou | D1P3 | 08 | 09 | PCD and Paediatrics 1 | A systematic review of growth-related parameters and nutritional status of patients with primary ciliary dyskinesia (PCD) |
| 85 | 43793_173 | Nena Karavasiloglou | D1P3 | 08 | 10 | PCD and Paediatrics 2 | Nutritional supplement use among people with primary ciliary dyskinesia |
| 86 | 43791_171 | Anna-Lena Katzke | D1P3 | 08 | 11 | PCD and Paediatrics 2 | Automatic reanalysis of genetic data from patients with Primary Ciliary Dyskinesia |
| 87 | 43794_174 | Eleni Kortianou | D1P3 | 08 | 12 | PCD and Paediatrics 2 | Cardiorespiratory responses during the modified Shuttle walk test in children with chronic suppurative lung diseases. Comparisons with healthy, age-matched peers. |
| 88 | 43796_176 | Eleni Kortianou | D1P3 | 08 | 13 | PCD and Paediatrics 2 | User satisfaction and co-designing a website for physiotherapy management for children with chronic suppurative lung diseases |
| 89 | 43767_141 | Panagiotis Dalamarinis | D1P3 | 08 | 14 | PCD and Paediatrics 2 | Using 6-Minute Walk Test and Chester Step Test for Detecting Exertional Desaturation in Children with Chronic Suppurative Lung Disease: A Pilot Study. |
| 90 | 43906_269 | MINJUN LIAO | D1P3 | 08 | 15 | PCD and Paediatrics 2 | Diagnostic Pitfall in High-Speed Video Analysis of Primary Ciliary Dyskinesia: A TTC12-Related Case with Mixed Ciliary Activity |
| 91 | 43905_268 | Ying Liu | D1P3 | 08 | 16 | PCD and Paediatrics 2 | AK8 deficiency causes primary ciliary dyskinesia with normal ciliary ultrastructure in humans and mice |
| 92 | 43756_131 | Regina Monteiro | D1P3 | 08 | 17 | PCD and Paediatrics 2 | Diagnostic Overlap Between PCD and CFTR Dysfunction: An Unresolved Case with Discordant Findings |
| 93 | 43514_74 | Ahmad Mohammad Alessa | D1P3 | 09 | 01 | Treatments | CASE REPORT: OPTIMIZING POSITIVE END-EXPIRATORY PRESSURE USING ESOPHAGEAL BALLOON CATHETER MONITORING IN ARDS |
| 94 | 43191_34 | Ezequiel Baran | D1P3 | 09 | 02 | Treatments | Real-World Outcomes of Nebulized Levofloxacin in Chronic Bronchial Infection and Non-Cystic Fibrosis Bronchiectasis: A Comparative Analysis from the INBREATHING Registry |
| 95 | 43625_83 | Robert Flowers | D1P3 | 09 | 03 | Treatments | Early Real-World Experience With Brensocatib in a Safety-Net Bronchiectasis Cohort |
| 96 | 43883_252 | Jiahui Han | D1P3 | 09 | 04 | Treatments | Multi-Target Mechanisms of Kale as a Dietary Intervention in Bronchiectasis: A Network Pharmacology and Molecular Simulation Study |
| 97 | 43806_183 | Jin Hwa Lee | D1P3 | 09 | 05 | Treatments | Impact of inhaled corticosteroids on survival in patients with bronchiectasis |
| 98 | 44093_449 | Andrade Rosa | D1P3 | 09 | 06 | Treatments | Incidence, Timing, and Risk Factors for Hepatotoxicity During First-Line Anti-Tuberculosis Therapy in a Multi-Health-System Real-World Cohort |
| 99 | 43816_191 | Judy Schloss | D1P3 | 09 | 07 | Treatments | Inhaled Tranexamic Acid Dosing and Environmental Medication Loss From Three Jet Nebulizer Configurations |
| 100 | 43246_36 | MINH DAO NGO | D2P1 | 02 | 14 | BASIC SCIENCE 2 | Bronchoalveolar oxysterols are associated with disease severity and lung function decline in bronchiectasis |
| 101 | 43724_105 | Leonid Ramov | D2P1 | 02 | 15 | BASIC SCIENCE 2 | An incidental finding of infected bronchiectasis in a patient with an Asthma COPD overlap exacerbation a 10-year follow up. |
| 102 | 43857_229 | Leonid Ramov | D2P1 | 02 | 16 | BASIC SCIENCE 2 | Rapidly Progressive Cystic Bronchiectasis in Suspected Primary Ciliary Dyskinesia: A Challenging Case with Recurrent Severe Exacerbations (Case Report) |
| 103 | 43805_182 | Ilona Rosenboom | D2P1 | 02 | 17 | BASIC SCIENCE 2 | Linking sputum metagenome composition to inflammatory profiles in bronchiectasis: a pilot study |
| 104 | 43517_75 | Elena Schneider-Futschik | D2P1 | 02 | 18 | BASIC SCIENCE 2 | Defining the Role of Dipeptidyl Peptidase-1 in Murine Lung Immune Regulation |
| 105 | 43792_172 | Siobhan Singh | D2P1 | 02 | 19 | BASIC SCIENCE 2 | To challenge or not to challenge? What can we learn from nebulised drug reaction assessment data in non-cystic fibrosis bronchiectasis? A retrospective study. |
| 106 | 43747_122 | Ruth Tal-Singer | D2P1 | 02 | 20 | BASIC SCIENCE 2 | Global Baseline Knowledge of Bronchiectasis: Results from the GAAPP Multilingual Online Interactive Quiz |
| 107 | 43651_89 | Aman Tiwari | D2P1 | 02 | 21 | BASIC SCIENCE 2 | Cigarette smoke extract and LPS trigger RIPK1/RIPK3/MLKL-mediated necroptosis and fibrotic lung injury |
| 108 | 43642_85 | Pauline Vermoesen | D2P1 | 02 | 22 | BASIC SCIENCE 2 | AIR-BREES: Airway Inhalation Risks—a Bronchiectasis Respiratory Environmental Exposure Survey |
| 109 | 43762_137 | Christine K. Wong | D2P1 | 02 | 23 | BASIC SCIENCE 2 | Pseudomonas aeruginosa infection increases sputum viscoelasticity and chronic inflammation in bronchiectasis |
| 110 | 44059_419 | Yingzhou Xie | D2P1 | 02 | 24 | BASIC SCIENCE 2 | The response regulator-encoding PA1437 controls antibiotic persistence in Pseudomonas aeruginosa and contributes to recalcitrant chronic infection in bronchiectasis |
| 111 | 43885_253 | B. Shoshana Zha | D2P1 | 02 | 25 | BASIC SCIENCE 2 | CFTR Function, Modulator Access, and Host-Pathogen Transcriptomics of M. avium in Bronchiectasis and NTM Lung Disease |
| 112 | 43713_97 | Ilgar Mustafayev | D2P1 | 03 | 15 | REGISTRIES & TRAILS 2 | Evaluation of Surfactant Therapy in the Treatment of Bronchiectasis |
| 113 | 43839_215 | Lidia Perea | D2P1 | 03 | 16 | REGISTRIES & TRAILS 2 | The frequent exacerbator phenotype in bronchiectasis revisited: Data from the EMBARC registry |
| 114 | 43776_150 | Michal Shteinberg | D2P1 | 03 | 17 | REGISTRIES & TRAILS 2 | Final pooled data from Phase II studies (AIRLEAF®, CLAIRLEAF®) of the dipeptidyl peptidase 1 (or Cathepsin C) inhibitor verducatib in bronchiectasis |
| 115 | 44026_416 | Colin Swenson | D2P1 | 03 | 18 | REGISTRIES & TRAILS 2 | Comparison of Aerobika versus other PEP therapies, in addition to inhaled hypertonic saline, among adult patients in the U.S. Bronchiectasis Research Registry |
| 116 | 43864_236 | Ruth Tal-Singer | D2P1 | 03 | 19 | REGISTRIES & TRAILS 2 | First International Multicenter Validation of the Chronic Airways Assessment Test (CAAT)™ in Bronchiectasis |
| 117 | 43869_240 | Stephanie Thee | D2P1 | 03 | 20 | REGISTRIES & TRAILS 2 | Nocturnal digital cough monitoring in people with Primary Ciliary Dyskinesia and Cystic Fibrosis – First results of an international multi-centre observational study |
| 118 | 43881_250 | Christina Thornton | D2P1 | 03 | 21 | REGISTRIES & TRAILS 2 | The Impact of Proton Pump Inhibitor (PPI) Use on Exacerbation Rates in Patients with Bronchiectasis: An Analysis of the US Bronchiectasis and NTM Research Registry |
| 119 | 43365_39 | Kazuya Tone | D2P1 | 03 | 22 | REGISTRIES & TRAILS 2 | Induced sputum collection using Lung Flute® ECO in suspected NTM pulmonary disease with bronchiectatic features: a prospective interim analysis |
| 120 | 43788_168 | Claire Wainwright | D2P1 | 03 | 23 | REGISTRIES & TRAILS 2 | Finding the Optimal Regimen for Mycobacterium abscessus Treatment (FORMaT) Trial: First Interim Analysis of 61 Intervention Participants after Short Intensive Therapy |
| 121 | 43866_238 | Meret Moormann | D2P1 | 04 | 09 | Comorbidities, Immunology & Inflammation 2 | Serum Club Cell Protein 16 (CC16) and its Association with Bronchiectasis Severity and Activity – Data from the German Bronchiectasis Registry PROGNOSIS |
| 122 | 43927_287 | Craig Schofield | D2P1 | 04 | 10 | Comorbidities, Immunology & Inflammation 2 | Single-cell RNA sequencing of induced sputum to characterise airway immune cells in paediatric bronchiectasis |
| 123 | 43777_158 | Michal Shteinberg | D2P1 | 04 | 11 | Comorbidities, Immunology & Inflammation 2 | Efficacy and Safety of Brensocatib in Patients With Non-Cystic Fibrosis Bronchiectasis and Comorbid Chronic Rhinosinusitis: A Subgroup Analysis of the ASPEN Trial |
| 124 | 43778_159 | Colin Swenson | D2P1 | 04 | 12 | Comorbidities, Immunology & Inflammation 2 | Efficacy and Safety of Brensocatib in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB) by ROSE Criteria: A Post Hoc Analysis of the ASPEN Trial |
| 125 | 43725_106 | Lynn Te Slaa | D2P1 | 04 | 13 | Comorbidities, Immunology & Inflammation 2 | Bronchiectasis as an underrecognized extra-intestinal manifestation of inflammatory bowel disease |
| 126 | 44020_412 | Rabindra Tirouvanziam | D2P1 | 04 | 14 | Comorbidities, Immunology & Inflammation 2 | Sputum metabolomics reveals a shared oxidant signature in non-CF and CF bronchiectasis |
| 127 | 43988_380 | Harm Tiddens | D2P1 | 04 | 15 | Comorbidities, Immunology & Inflammation 2 | Bronchiectasis Without Dilatation? How Emphysema Confounds CT Diagnosis |
| 128 | 43764_139 | Aditi Loewe | D2P1 | 05 | 13 | Cystic Fibrosis and Bronchiectasis 2 | Novel Polymeric Reducing Agents as Mucus Modulators in Cystic Fibrosis |
| 129 | 43842_217 | Gabriele Matschiner | D2P1 | 05 | 14 | Cystic Fibrosis and Bronchiectasis 2 | ATL-105, a novel multimodal serine protease inhibitor with immunomodulatory and anti-infective properties for the treatment of non-CF bronchiectasis |
| 130 | 43545_76 | Jia hui He | D2P1 | 05 | 15 | Cystic Fibrosis and Bronchiectasis 2 | Multidimensional Assessment of the Clinical Evolution of Asthma-Bronchiectasis Overlap |
| 131 | 43195_35 | Jakob Raith | D2P1 | 05 | 16 | Cystic Fibrosis and Bronchiectasis 2 | Clinical implications of traction bronchiectasis in IPF and fibrotic RA-ILD – A retrospective single-center cohort study |
| 132 | 43896_262 | Virginia Santello | D2P1 | 05 | 17 | Cystic Fibrosis and Bronchiectasis 2 | Oscillometry in the assessment of disease activity and severity in bronchiectasis |
| 133 | 43396_49 | Hisham Saumtally | D2P1 | 05 | 18 | Cystic Fibrosis and Bronchiectasis 2 | The LTAP-Treated Bronchiectasis Phenotype: Severity, Exacerbation Burden and Microbiological Risk in a Large Tertiary Centre Cohort |
| 134 | 43715_99 | Constance Takawira | D2P1 | 05 | 19 | Cystic Fibrosis and Bronchiectasis 2 | Patient-focused Target Product Profiles for the development of phage therapies to treat lung infections in cystic fibrosis |
| 135 | 43817_192 | Ruth Tal-Singer | D2P1 | 05 | 20 | Cystic Fibrosis and Bronchiectasis 2 | Patient engagement and collaboration in the design of the Phase III AIRTIVITY® study in people living with bronchiectasis |
| 136 | 43807_184 | Laura Tasca | D2P1 | 05 | 21 | Cystic Fibrosis and Bronchiectasis 2 | Compartmentalized PDE3/4 Modulation by Inhaled KIT2014 Improves Airway Epithelial Function and Limits Inflammation in in Non-Cystic Fibrosis Bronchiectasis-relevant models |
| 137 | 43761_136 | Wen-Wen Wang | D2P1 | 05 | 22 | Cystic Fibrosis and Bronchiectasis 2 | A Mismatch Between Physiology and Treatment in Bronchiectasis with Airflow Obstruction—Data from BE-China |
| 138 | 43922_282 | Shoshana Zha | D2P1 | 05 | 23 | Cystic Fibrosis and Bronchiectasis 2 | Characterizing CFTR-Related Disorder Bronchiectasis and Response to Modulator Therapy: A Prospective Multicenter Registry Cohort |
| 139 | 43872_243 | Ahmad Mohammad Alessa | D2P2 | 06 | 01 | Infections | Refractory Pediatric ARDS Due to Tuberculosis Managed with V-V ECMO: Case Report |
| 140 | 43765_140 | Fengming Ding | D2P2 | 06 | 02 | Infections | Association of inhaled corticosteroid use and acquiring Pseudomonas aeruginosa in eosinophilic bronchiectasis patients |
| 141 | 43854_226 | Warnakulasuriya Susanne Nirodhani Fernando | D2P2 | 06 | 03 | Infections | Bacteriological Profile of Sputum Pyogenic Cultures, Associated Comorbidities, and Complications in Patients with Bronchiectasis Admitted to a Tertiary Care Respiratory Unit in Sri Lanka: A Descriptive Case Series- Preliminary report |
| 142 | 43760_135 | Freddy Frost | D2P2 | 06 | 04 | Infections | 50 shades of green: Longitudinal dynamics of sputum colour and associated clinical outcomes in bronchiectasis |
| 143 | 43763_138 | Espen E Groth | D2P2 | 06 | 05 | Infections | Intra-host Pseudomonas aeruginosa dynamics under antibiotic pressure in COPD and non-CF bronchiectasis: results from an observational trial. |
| 144 | 43795_175 | Moshe Heching | D2P2 | 06 | 06 | Infections | Taking a shot at the future: Impact of vaccination compliance on exacerbations in bronchiectasis patients |
| 145 | 44084_442 | De Sanctis Jorgelina | D2P2 | 06 | 07 | Infections | Evolving Multidrug-Resistant Pseudomonas aeruginosa and Nontuberculous Mycobacterial Infections in Cystic Fibrosis Bronchiectasis Through Bilateral Lung Transplantation |
| 146 | 44068_427 | Nguyen-Ho Lam | D2P2 | 06 | 08 | Infections | Etiological and Microbiological Phenotypes of Non-Cystic Fibrosis Bronchiectasis in Vietnam: A High Tuberculosis-Burden Cohort |
| 147 | 43757_132 | Yue Su | D2P2 | 06 | 09 | Infections | AI-Based Risk Prediction of Pseudomonas aeruginosa and NTM Infections in Bronchiectasis Patients Using Chest CT Imaging |
| 148 | 43856_228 | Georg Vrana | D2P2 | 06 | 10 | Infections | Treatment Outcomes in Chronic Pulmonary Aspergillosis: A Single-Center Retrospective Analysis |
| 149 | 43815_190 | Zhongbo Chen | D2P2 | 07 | 10 | NTM 2 | The Immune–Metabolic–Pathogen Interaction Network of PD-1⺠T Cell Glycolytic Reprogramming and LAM/Extracellular Vesicles in Non-tuberculous Mycobacterial Pulmonary Disease |
| 150 | 43894_261 | P. Makani | D2P2 | 07 | 11 | NTM 2 | Quantification of structural lung abnormalities in a cohort bronchiectasis patients with and without Nontuberculous Mycobacteria using the manual BEST-NTM score |
| 151 | 44060_420 | Carla McWilliams | D2P2 | 07 | 12 | NTM 2 | Nontuberculous Mycobacteria Commonly Detected in Bronchoscopy Patients Without Prior Clinical Suspicion in an Endemic Region |
| 152 | 43389_44 | Hisham Saumtally | D2P2 | 07 | 13 | NTM 2 | Identifying Vulnerable Patients in NTM PD: Respiratory Comorbidity and Treatment Intolerance Drive Mortality Risk |
| 153 | 43359_38 | Johnny Che I Su | D2P2 | 07 | 14 | NTM 2 | CHARACTERISATION OF ADULT PATIENTS WITH BRONCHIECTASIS AND SPINAL DEFORMITIES |
| 154 | 44085_443 | Harm Tiddens | D2P2 | 07 | 15 | NTM 2 | Automatic Mucus Plug Quantification in Bronchiectasis Patients with NTM Infection |
| 155 | 43878_247 | Simone Tunesi | D2P2 | 07 | 16 | NTM 2 | Epidemiology and Spatial Distribution of Non-Tuberculous Mycobacteria in a North Italian Region |
| 156 | 43877_246 | Simone Tunesi | D2P2 | 07 | 17 | NTM 2 | When a diagnosis doesn’t follow the script: a case report of a M. abscessus pulmonary disease mimicking a rare condition in a bronchiectasic patient |
| 157 | 43397_50 | Sigrid van Brummelen | D2P2 | 07 | 18 | NTM 2 | NTM mapping in the Rotterdam region in the Netherlands |
| 158 | 43797_177 | Cara Varley | D2P2 | 07 | 19 | NTM 2 | Changes in Complete Blood Count During 12 Months of Treatment for Mycobacterium avium complex Pulmonary Disease: A MAC 2v3 analysis |
| 159 | 44063_423 | James O'Hanlon | D2P2 | 08 | 18 | PCD and Paediatrics 3 | A family with primary ciliary dyskinesia (PCD) from pathogenic variants in HYDIN – a case series |
| 160 | 43934_304 | Charlotte O. Pioch | D2P2 | 08 | 19 | PCD and Paediatrics 3 | Comparison of cut-off values for nasal nitric oxide measurements in children under four years of age |
| 161 | 44086_444 | Robert Reklow | D2P2 | 08 | 20 | PCD and Paediatrics 3 | An Optimized Immunofluorescence Panel Improves Diagnostic Accuracy for Primary Ciliary Dyskinesia |
| 162 | 44073_432 | Amelia Shoemark | D2P2 | 08 | 21 | PCD and Paediatrics 3 | Characteristics and outcomes of adults with bronchiectasis due to primary ciliary dyskinesia: combined analysis of EMBARC, Australia, USA and Canadian bronchiectasis registries |
| 163 | 43913_276 | Ben O. Staar | D2P2 | 08 | 22 | PCD and Paediatrics 3 | Integrated Structural, Functional, and Clinical Characterization of NME5 in Primary Ciliary Dyskinesia |
| 164 | 44208_503 | Lea Terbeck | D2P2 | 08 | 23 | PCD and Paediatrics 3 | Establishing Scanning Electron Microscopy for air-liquid interface cultures of individuals with ciliopathies |
| 165 | 43770_144 | Tanya Theriault | D2P2 | 08 | 24 | PCD and Paediatrics 3 | Implementation of emotional wellness questionnaires in primary ciliary dyskinesia clinic: A social work led quality improvement project |
| 166 | 43916_278 | Dörthe Thüß | D2P2 | 08 | 25 | PCD and Paediatrics 3 | AK8 deficiency causes primary ciliary dyskinesia by disrupting energy homeostasis in the airways |
| 167 | 43800_179 | Dan-hui Yang | D2P2 | 08 | 26 | PCD and Paediatrics 3 | In Vitro Gene Therapy Study of Primary Ciliary Dyskinesia Based on DNAI1-mRNA Lipid Nanoparticles |
| 168 | 43513_73 | Ahmad Mohammad Alessa | D2P3 | 01 | 01 | Respiratory Physiotherapy and Airway Clearance | The Impact Of Prone Positioning As A Respiratory Therapy Protocol In ICU Patients, Scoping Review |
| 169 | 44194_494 | Martina Santambrogio | D2P3 | 01 | 02 | Respiratory Physiotherapy and Airway Clearance | Feasibility and Clinical Utility of Forced Oscillation Technique (FOT) as an Outcome Measure for Airway Clearance Efficacy in Non-Cystic Fibrosis Bronchiectasis: A Pilot Study |
| 170 | 43917_279 | Beatriz Herrero-Cortina | D2P3 | 01 | 03 | Respiratory Physiotherapy and Airway Clearance | Inflammation, Cardiac Autonomic Function, and Exercise Capacity in Bronchiectasis: Exploring Interrelated Mechanisms |
| 171 | 44025_415 | Rhiannon Jones | D2P3 | 01 | 04 | Respiratory Physiotherapy and Airway Clearance | Physiotherapy Support Staff in Airway Clearance: A Competency‑Led Approach |
| 172 | 43774_148 | Eleni Kortianou | D2P3 | 01 | 05 | Respiratory Physiotherapy and Airway Clearance | Association Between Airway Clearance Technique Adherence and Exacerbation Risk in Children and Adolescents With Non-Cystic Fibrosis Bronchiectasis: A Retrospective Cohort Study |
| 173 | 43758_133 | Yang Liu | D2P3 | 01 | 06 | Respiratory Physiotherapy and Airway Clearance | Airway clearance management for bronchiectasis in China: a multicentre cross-sectional study from the Chinese Bronchiectasis Registry (BE-China) |
| 174 | 44141_487 | Bei Mao | D2P3 | 01 | 07 | Respiratory Physiotherapy and Airway Clearance | Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis with exacerbation: a multicenter randomized controlled clinical trial |
| 175 | 43495_67 | Helper Nir | D2P3 | 01 | 08 | Respiratory Physiotherapy and Airway Clearance | Mechanical insufflator exsufflation as means for airway clearance in children with non CF- bronchiectasis – a case report |
| 176 | 43440_59 | Erick Ouma | D2P3 | 01 | 09 | Respiratory Physiotherapy and Airway Clearance | Effectiveness of mucolytic-assisted respiratory physiotherapy in optimizing airway clearance among patients with chronic bronchiectasis: A case report in Nairobi, Kenya. |
| 177 | 43819_194 | MERTSCH Pontus | D2P3 | 01 | 10 | Respiratory Physiotherapy and Airway Clearance | Real‑World evidence of Simeox airway clearance device in Muco‑Obstructive Lung Diseases: Results of the German Prospective Multicenter IMPROVE Study |
| 178 | 44206_502 | Martina Santambrogio | D2P3 | 01 | 11 | Respiratory Physiotherapy and Airway Clearance | Pelvic Floor Dysfunctions in Non-CF Bronchiectasis: A Pilot Study |
| 179 | 43824_197 | Svenja Strassburg | D2P3 | 01 | 12 | Respiratory Physiotherapy and Airway Clearance | An Investigation into Different Oscillating Positive Expiratory Pressure (OPEP) Devices, Assessing Laboratory Metrics Relevant to Performance |
